Open AccessInvitro Activities of Polymyxins and Rifampicin against Carbapenem Resistant Acinetobacter baumannii at a Tertiary Care Hospital from South India
Author(s) -
Dheepa Muthusamy,
S Sudhishnaa,
B Appalaraju
Publication year - 2016
Publication title -
journal of clinical and diagnostic research
Language(s) - English
Resource type - Journals
eISSN - 2249-782X
pISSN - 0973-709X
DOI - 10.7860/jcdr/2016/19968.8535
Subject(s) - colistin , acinetobacter baumannii , polymyxin , polymyxin b , microbiology and biotechnology , rifampicin , antibiotics , carbapenem , acinetobacter , biology , medicine , pseudomonas aeruginosa , bacteria , genetics
Acinetobacter baumannii ( A.baumannii ) is rapidly emerging as a potent organism causing a multitude of nosocomial infections. The organism also carries various resistance mechanisms to antibiotics, making treatment more difficult. Very few choices are left, as A.baumannii strains have begun to develop resistance against cephalosporins, aminoglycosides and even carbapenems.